Optimisation of a functional mycobacterial growth-inhibition assay to improve its suitability for infant TB vaccine studies

Journal of Immunological Methods

Volumn 394, Issue 1-2, 2013, Pages 121-124

  Burl, S ^a   Holder, B S ^a   Lo, B K M ^a   Kampmann, B ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b MRC Unit   (Gambia)

Author keywords

BCG lux; Mycobacterium tuberculosis; Paediatric tuberculosis; Vaccine immunogenicity

Indexed keywords

BCG VACCINE;

ARTICLE; BACTERIAL GROWTH; BCG VACCINATION; BLOOD SAMPLING; BLOOD VOLUME; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MARKER; ERYTHROCYTE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOGENICITY; IMMUNOPATHOGENESIS; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTE; PRIORITY JOURNAL; PROTECTION; REPORTER GENE; SUPERNATANT;

BCG-LUX; MYCOBACTERIUM TUBERCULOSIS; PAEDIATRIC TUBERCULOSIS; VACCINE IMMUNOGENICITY;

ADULT; BCG VACCINE; HUMANS; INFANT; MICROBIOLOGICAL TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 84880047150     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.05.006     Document Type: Article

References (11)

1. Fine P.E., Sterne J.A., Ponnighaus J.M., Rees R.J. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994, 344:1245.
2. Kagina B.M., Abel B., Scriba T.J., Hughes E.J., Keyser A., Soares A., Gamieldien H., Sidibana M., Hatherill M., Gelderbloem S., Mahomed H., Hawkridge A., Hussey G., Kaplan G., Hanekom W.A. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns. Am. J. Respir. Crit. Care Med. 2010, 182:1073.
3. Kampmann B., Gaora P.O., Snewin V.A., Gares M.P., Young D.B., Levin M. Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. J. Infect. Dis. 2000, 182:895.
4. Kampmann B., Tena G.N., Mzazi S., Eley B., Young D.B., Levin M. Novel human in vitro system for evaluating antimycobacterial vaccines. Infect. Immun. 2004, 72:6401.
5. Kampmann B., Tena-Coki G.N., Nicol M.P., Levin M., Eley B. Reconstitution of antimycobacterial immune responses in HIV-infected children receiving HAART. AIDS (London, England) 2006, 20:1011.
6. Martineau A.R., Wilkinson K.A., Newton S.M., Floto R.A., Norman A.W., Skolimowska K., Davidson R.N., Sorensen O.E., Kampmann B., Griffiths C.J., Wilkinson R.J. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol. 2007, 178:7190.
7. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 2008, 149:177.
8. Silver R.F., Li Q., Ellner J.J. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect. Immun. 1998, 66:1190.
9. Snewin V.A., Gares M.P., Gaora P.O., Hasan Z., Brown I.N., Young D.B. Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect. Immun. 1999, 67:4586.
10. Tameris M.D., Hatherill M., Landry B.S., Scriba T.J., Snowden M.A., Lockhart S., Shea J.E., McClain J.B., Hussey G.D., Hanekom W.A., Mahomed H., McShane H. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013, (epub ahead of print, in press).
11. Worku S., Hoft D.F. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guerin. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2000, 30(Suppl. 3):S257.